Echolight, a global innovator in bone densitometry, announced that it has signed an agreement enabling Siemens Healthineers to be a reseller of Echolight bone densitometers in support of its women’s health solutions.
Echolight’s REMS (Radiofrequency Echographic Multi Spectometry) technology measures bone density and microarchitecture without using the radiation of traditional X-ray scans but instead through a simple ultrasound scan of axial anatomical sites such as the spine and femur. This radiation-free technology allows physicians to perform repeated scans for monitoring bone health over time. In addition, the ability to automatically exclude artifacts commonly present with other densitometry procedures yields a highly reliable diagnostic assessment.
“Bone health is a serious problem here in the U.S. This agreement provides expanded provider and patient access to REMS technology in the U.S. through ultrasound-based bone density scanning as another option in the effort to diagnose and monitor bone health. Echolight is pleased to support Siemens Healthineers in their focus on women’s health and bone disease,” explained Thomas J. McLaughlin, executive commercial director, Echolight USA.
Echolight’s portable solution measures bone quantity and quality simultaneously, through evaluation of bone mineral density at the lumbar vertebrae (L1-L4) and the femoral neck providing all common parameters of the diagnosis of osteoporosis BMD (g/cm2), T-scores, and Z-score. It also measures fragility score through an independent assessment of internal bone structure to evaluate the risk of fracture in 5 years through dedicated statistical and spectral analysis. Siemens Healthineers will be offering the Echos Plus, Echostation, and Echohybrid Plus models.
For more information, visit the Echolight booth #1853 at the RSNA Annual Meeting.
